C12N 2710/20061
Methods of inactivation or attenuation
C12N2710/20061 (Methods of inactivation or attenuation) appears on 9 US grants and 19 published applications in this corpus.
Search patents in C12N- Granted patents
- 9
- Published applications
- 19
- Assignees
- 7
- Inventors
- 14
- Latest grant
- 20 May 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 1 | 1 |
| 2006 | 0 | 0 |
| 2007 | 1 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 1 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 1 |
| 2019 | 0 | 3 |
| 2020 | 1 | 0 |
| 2021 | 0 | 1 |
| 2022 | 1 | 4 |
| 2023 | 1 | 2 |
| 2024 | 0 | 3 |
| 2025 | 1 | 0 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Compositions, methods and uses for thermally stable multi-targeted antigens20 May 2025US 12,303,602 B2The Regents of the University of Colorado, a body corporate
- Compositions, methods and uses for thermally stable multi-targeted antigens7 Nov 2023US 11,806,432 B2The Regents of the University of Colorado, a body corporate
- Compositions, methods and uses for thermally stable multi-targeted antigens15 Mar 2022US 11,273,127 B2The Regents of the University of Colorado, a body corporate
- Method for preventing or treating viral infection and tumor21 Jul 2020US 10,716,769 B2Guangzhou Jtreat Biosci. Ltd.
- Papilloma pseudovirus and preparation6 Mar 2012US 8,129,144 B2Loyola University of Chicago
- Compositions, methods and uses for thermally stable multi-targeted antigens11 Jul 2024US 2024/0226015 A9The Regents of the University of Colorado, a body corporate
- Compositions, methods and uses for thermally stable multi-targeted antigens25 Apr 2024US 2024/0130973 A1The Regents of the University of Colorado, a body corporate
- T cell-directed anti-cancer vaccines against commensal viruses for treating mucosal carcinomas28 Mar 2024US 2024/0100141 A1The General Hospital Corporation
- Compositions, methods and uses for thermally stable human papillomavirus formulations9 Nov 2023US 2023/0355739 A1The Regents of the University of Colorado, a body corporate
- Compositions, methods and uses for thermally stable human papillomavirus formulations21 Sep 2023US 2023/0293662 A1The Regents of the University of Colorado, a body corporate
Most cited
By later US patents
- Papilloma pseudovirus and preparation22US 7,205,126 B2Loyola University of Chicago · 2007
- DNA coding for a peptide of a papilloma virus main capside protein and use thereof7US 6,025,163 ADeutsches Krebsforschungzentrum Stiftung des Offentlichen Rechts · 2000
- Papilloma pseudo-virus and preparation3US 6,878,541 B22005
- DNA coding for a peptide of a papilloma virus main capside protein and use thereof1US 6,395,512 B1Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts · 2002